|
MechanismFGFR2 antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1/2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with 3H (Shanghai) Pharmaceuticals Co., Ltd
0 Patents (Medical) associated with 3H (Shanghai) Pharmaceuticals Co., Ltd
100 Deals associated with 3H (Shanghai) Pharmaceuticals Co., Ltd
100 Translational Medicine associated with 3H (Shanghai) Pharmaceuticals Co., Ltd